Related Experiment Video
Updated: May 13, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Glymphatic system dysfunction and its impact on seizure severity, cognitive function, and affective symptoms in
Qibing Sun1, Jinshuai Liu1, Zifan Yang1
1Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Background:
Generalized tonic-clonic seizures alone (GTCS alone) represent a distinct idiopathic epilepsy syndrome. Glymphatic system (GS) dysfunction-a brain-wide perivascular clearance pathway-has been proposed as a contributing mechanism in epilepsy and its related comorbidities.
Objective:
To assess GS function in patients with GTCS alone using the Analysis Along the Perivascular Space (ALPS) index derived from diffusion spectrum imaging (DSI), and to explore its associations with clinical, cognitive, and emotional measures.
Methods:
A total of 101 patients with GTCS alone and 76 demographically matched healthy controls underwent DSI. The ALPS index was calculated and correlated with scores from standardized assessments, including the National Hospital Seizure Severity Scale (NHS3), Epileptic Discharge Index (EDI), Montreal Cognitive Assessment (MoCA), Kilifi Stigma Scale for Epilepsy (KSSE), and Hamilton Depression Rating Scale (HAMD).
Results:
Patients with GTCS alone had lower ALPS indices compared to healthy controls (1.43 vs. 1.52, p < 0.01). Among patients, the ALPS index positively correlated with MoCA scores (r = 0.30, p = 0.002) and negatively correlated with age (r = -0.22, p = 0.030), NHS3 (r = -0.27, p = 0.007), KSSE (r = -0.21, p = 0.038), and HAMD (r = -0.20, p = 0.042). The ALPS index was lower in patients with higher antiseizure medication loads (1.36 vs. 1.44, p = 0.042) and elevated EDI values (1.39 vs. 1.45, p = 0.039).
Conclusions:
Glymphatic function is impaired in patients with GTCS alone, as indicated by reduced ALPS indices. These indices are associated with seizure severity, cognitive impairment, depressive symptoms, and perceived stigma. The ALPS index may serve as a noninvasive imaging biomarker of disease burden and a novel tool for understanding pathophysiological mechanisms in GTCS alone.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists

